| Pinnacle Hearing Llc | |
|
415 Hospital Dr, Camden, AR 71701-4615 | |
| (870) 837-2823 | |
| (870) 617-1602 |
| Full Name | Pinnacle Hearing Llc |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 415 Hospital Dr, Camden, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154001667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pinnacle Hearing Llc 415 Hospital Dr, Camden, AR 71701-4615 Ph: (870) 837-2823 | Pinnacle Hearing Llc 415 Hospital Dr, Camden, AR 71701-4615 Ph: (870) 837-2823 |
News Archive
Minneapolis is set to become a national epicenter of healthcare data thought leadership and policy discussion this September when the city plays host to the fifth annual Healthcare Business Intelligence Summit.
Lung cancer is the No. 1 cause of cancer deaths in the United States, despite the fact it is largely preventable. For people at high risk of developing lung cancer, such as current or former longtime smokers, screening for the disease with low-dose CT scans is now a viable option that has been shown to significantly reduce mortality rates. In conjunction with National Lung Cancer Awareness Month, Seattle Cancer Care Alliance (SCCA) wants to raise awareness about the importance of prevention and early detection for at-risk populations.
Dieters and weight loss researchers are familiar with the principle: The more weight you've lost, the harder it is to keep it off. A complex and vicious cycle of biological and behavioral factors make it so.
Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).
› Verified 2 days ago